Perella Weinberg Partners Capital Management’s AbbVie ABBV Stock Holding History

Perella Weinberg Partners Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-10,568	Closed	-$852K	–	223
2019 Q1	$852K	Sell	10,568 -333	-3%	-$27.2K	0.04%	176
2018 Q4	$1M	Sell	10,901 -28,672	-72%	-$2.52M	0.06%	164
2018 Q3	$3.74M	Buy	+39,573	New	+$3.75M	0.17%	117
2018 Q2	–	Sell	-26,349	Closed	-$2.49M	–	189
2018 Q1	$2.49M	Buy	26,349 +14,352	+120%	+$1.58M	0.11%	148
2017 Q4	$1.16M	Sell	11,997 -10,627	-47%	-$1M	0.11%	103
2017 Q3	$2.01K	Sell	22,624 -19,631	-46%	-$1.49M	0.17%	100
2017 Q2	$3.06M	Buy	42,255 +19,631	+87%	+$1.32M	0.38%	77
2017 Q1	$1.47M	Buy	22,624 +5,422	+32%	+$341K	0.24%	66
2016 Q4	$1.08M	Buy	+17,202	New	+$1.05M	0.27%	77

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Perella Weinberg Partners Capital Management's ABBV Position: Q2 2019 in Review

Perella Weinberg Partners Capital Management sold out of AbbVie (ABBV) in Q2 2019, closing a stake of 10,568 shares — an estimated $852K sold.

Perella Weinberg Partners Capital Management first reported a position in ABBV in Q4 2016 and held it in 9 quarters. The position peaked at $3.74M in Q3 2018. 2,021 funds tracked by Wall St. Rank hold ABBV as of Q2 2019.

Perella Weinberg Partners Capital Management reported no remaining AbbVie position as of Q2 2019 after selling out during the quarter.
Perella Weinberg Partners Capital Management sold 10,568 AbbVie shares in Q2 2019, an estimated $852K.
Perella Weinberg Partners Capital Management first reported a position in AbbVie in Q4 2016 and held it in 9 quarters.
Perella Weinberg Partners Capital Management's AbbVie position peaked at $3.74M in Q3 2018.
2,021 funds tracked by Wall St. Rank held AbbVie as of Q2 2019.

Based on Perella Weinberg Partners Capital Management's 13F filing for Q2 2019, filed 22 Jul 2019.